-1.png)
Our Audience
Our audience is made up of the teams that buy from suppliers like you. They work in process and analytical development, quality, supply chain, and regulatory affairs, developing and commercializing cell and gene therapies. They register with BioInsights for practical answers to the problems your products and services solve.
We put your content in front of them on the topics they already come to us for. Our editors are subject specialists who work with leading experts every day, and they shape your material into the formats these readers use.
Matched to the problem you solve: coverage includes scaling AAV and lentiviral vector manufacturing; development challenges across autologous, allogeneic, and in vivo CAR-T; potency assays and analytics for CMC; and automated, closed manufacturing platforms. You reach the readers working on the problem your product addresses.
Targeted by topic, not just job title: every reader registers against at least one specific topic. You choose the problem area, and we reach the people working on it.
The credibility of an expert-led platform: the journals are shaped by advisory boards that include directors of academic GMP facilities, CMC assessors from national regulators, and heads of process development and CMC at therapy developers. Your content carries the BioInsights name.
Attention you can see: a median of 254 registrations per webinar and 46 minutes average viewing time. Registrations and performance are reported to you.
